As we mentioned a few weeks ago, we welcomed our first Calmare Therapy patient from Europe (Amsterdam) this week who is undergoing treatment to combat chronic bilateral foot pain as a result of chemotherapy-induced peripheral neuropathy, or CIPN. As we and others have shared in the past, CIPN pain is notoriously difficult to treat successfully.
Our patient contracted CIPN three months after undergoing chemotherapy for breast cancer more than three years ago. Her pain level escalated to a seven and she began having difficulty walking. She is undergoing 10 Calmare treatments and her outcome looks very positive. We look forward to sharing her outcome as she therapy progresses.
Dr. Michael Cooney
Advertisements
December 9, 2011 at 7:32 am
Looking forward to hearing the Mayo Clinic Calmare (scrambler) study results. From what U of W. is reporting, expect to hear their have positive reports on using it for chemo pain. This can help 1000s of cancer suvivors. Good CHristmas present. Any idea when their results are going to come out?
December 9, 2011 at 7:26 am
Hearing great things about Calmare treatment for CIPN from my friends out west. My sister suffers from this condition and has not found anything (including medication) to help with the pain. She also has the pain concentrated in hands and feet. She’s only 37. It is apalling that there are so few treatments for this kind of pain. Glad you are offering this to cancer survivors and even more importantly–we are hearing it works!!!